SPINRAZA 28 mg, SPINRAZA 50 mg
232SM303
Phase 3 small_molecule active
Quick answer
SPINRAZA 28 mg, SPINRAZA 50 mg for Spinal Muscular Atrophy is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen Idec Ltd
- Indication
- Spinal Muscular Atrophy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active